Molecular and biochemical basis for the platelet dysfunction in myeloproliferative disorders

Seminars in Hematology

Volumn 41, Issue 2 SUPPL. 3, 2004, Pages 6-9

  Rao, A Koneti ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR;

BIOCHEMISTRY; BLEEDING; CELL INTERACTION; CELL SURFACE; HUMAN; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SYMPTOMATOLOGY; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE DYSFUNCTION; THROMBOSIS;

EID: 2442690282     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2004.02.010     Document Type: Article

References (17)

1. Rao AK: Acquired disorders of platelet function, in Michelson AD (ed): Platelets. New York, NY, Academic Press, 2002, pp 701-726
2. Rao AK: Disorders of platelet function, in Kitchens C, Alying B, Kessler CM (eds): Consultative Hemostasis and Thrombosis. Philadelphia, PA, Saunders, 2002, pp 133-148
3. van Genderen PJ, Michiels JJ, van Strik R, Lindemans J, van Vliet HH: Platelet consumption in thrombocythemia complicated by erythromelalgia: Reversal by aspirin. Thromb Haemost 73:210-214, 1995
4. Kaywin P, McDonough M, Insel PA, Shattil SJ: Platelet function in essential thrombocythemia. Decreased epinephrine responsiveness associated with a deficiency of platelet alpha-adrenergic receptors. N Engl J Med 299:505-509, 1978
5. 3H]dihydroergocryptine. J Clin Invest 74:1063-1072, 1984
6. 3H yohimbine in patients with myeloproliferative disorders. Thromb Res 40:623-629, 1985
7. Ushikubi F, Ishibashi T, Narumiya S, Okuma M: Analysis of the defective signal transduction mechanism through the platelet thromboxane A2 receptor in a patient with polycythemia vera. Thromb Haemost 67:144-146, 1992
8. Moliterno AR, Hankins WD, Spivak JL: Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med 338:572-580, 1998
9. Eche N, Sie P, Caranobe C, Nouvel C, Pris J, Boneu B: Platelets in myeloproliferative disorders. III: Glycoprotein profile in relation to platelet function and platelet density. Scand J Haematol 26:123-129, 1981
10. Clezardin P, McGregor JL, Dechavanne M, Clemetson KJ: Platelet membrane glycoprotein abnormalities in patients with myeloproliferative disorders and secondary thrombocytosis. Br J Haematol 60:331-344, 1985
11. Mazzucato M, De Marco L, De Angelis V, De Roia D, Bizzaro N, Casonato A: Platelet membrane abnormalities in myeloproliferative disorders: decrease in glycoproteins Ib and IIb/IIIa complex is associated with deficient receptor function. Br J Haematol 73:369-374, 1989
12. 125I-fibrinogen binding to platelets in myeloproliferative disease. Thromb Haemost 66:329-333, 1991
13. Kaplan R, Gabbeta J, Sun L, Mao GF, Rao AK: Combined defect in membrane expression and activation of platelet GPIIb-IIIa complex without primary sequence abnormalities in myeloproliferative disease. Br J Haematol 111:954-964, 2000
14. Handa M, Watanabe K, Kawai Y, Kamata T, Koyama T, Nagai H, Ikeda Y: Platelet unresponsiveness to collagen: Involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder. Thromb Haemost 73:521-528, 1995
15. Moore A, Nachman RL: Platelet Fc receptor. Increased expression in myeloproliferative disease. J Clin Invest 67:1064-1071, 1981
16. Thibert V, Bellucci S, Cristofari M, Gluckman E, Legrand C: Increased platelet CD36 constitutes a common marker in myeloproliferative disorders. Br J Haematol 91:618-624, 1995
17. Schafer AI: Deficiency of platelet lipoxygenase activity in myeloproliferative disorders. N Engl J Med 306:381-386, 1982